Chinmay Jani, MD (IMAGE)
Caption
Chinmay Jani, M.D., Sylvester chief fellow in hematology and oncology, will present his team’s ongoing phase I clinical trial at the 2026 ASCO conference. The study looks at escalating doses of a drug combination that may benefit patients with high-grade neuroendocrine tumors.
Credit
Sylvester Comprehensive Cancer Center
Usage Restrictions
Use with attribution
License
Original content